Pseudolaric Acid C2

CAS No. 82508-35-8

Pseudolaric Acid C2( —— )

Catalog No. M22829 CAS No. 82508-35-8

Pseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 159 In Stock
5MG 144 In Stock
10MG 235 In Stock
25MG 397 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pseudolaric Acid C2
  • Note
    Research use only, not for human use.
  • Brief Description
    Pseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.
  • Description
    Pseudolaric Acid C2 is a diterpenoid isolated from Pseudolarix kaempferi.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82508-35-8
  • Formula Weight
    418.44
  • Molecular Formula
    C22H26O8
  • Purity
    >98% (HPLC)
  • Solubility
    NA
  • SMILES
    CC(O[C@]12[C@@]3(CC=C(C(O)=O)CC2)C(O[C@@](/C=C/C=C(C)/C(O)=O)(C)[C@]1([H])CC3)=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu P, et al. Simultaneous determination of seven major diterpenoids in Pseudolarix kaempferi by high-performance liquid chromatography DAD method. J Pharm Biomed Anal. 2007 Jul 27;44(3):730-6.
molnova catalog
related products
  • Gnetifolin K

    Gnetifolin K (GnetifolinK) is a novel stilbene diglucoside from Gnetum parvifolium with potential neuroprotective activity for the study of DNA damage.

  • 7-O-Methylaloeresin ...

    7-O-Methylaloeresin A shows significant antioxidant activity, it also has moderate inhibitory active on BACE.

  • Sisunatovir HCl

    Sisunatovir HCl is an orally available inhibitor of the RSV-F protein that has exhibited potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses in vitro.